Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Filed Feb 9, 2021 · 10-Q · 40 days after period end · 0001193125-21-033243
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $1.00K | $77.00K |
| Net Income | -$3.25M | -$2.09M |
| EPS Diluted | -$0.76 | -$2.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 9, 2021 · 40 d after period end
